Titlebook: Biomarkers in Cardiovascular Disease; Vinood B. Patel,Victor R. Preedy Reference work 2016 Springer Science+Business Media Dordrecht 2016

近地點

書目名稱Biomarkers in Cardiovascular Disease影響因子(影響力)




書目名稱Biomarkers in Cardiovascular Disease影響因子(影響力)學(xué)科排名




書目名稱Biomarkers in Cardiovascular Disease網(wǎng)絡(luò)公開度




書目名稱Biomarkers in Cardiovascular Disease網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Biomarkers in Cardiovascular Disease被引頻次




書目名稱Biomarkers in Cardiovascular Disease被引頻次學(xué)科排名




書目名稱Biomarkers in Cardiovascular Disease年度引用




書目名稱Biomarkers in Cardiovascular Disease年度引用學(xué)科排名




書目名稱Biomarkers in Cardiovascular Disease讀者反饋




書目名稱Biomarkers in Cardiovascular Disease讀者反饋學(xué)科排名

全面

Cocker

Cardiovascular Disease Biomarkers in Clinical Use and Their Modulation by Functional Foodsion are strong risk factors for cardiovascular disease (CVD), a leading cause of morbidity and mortality worldwide. Consequently, biomarkers reflecting blood glucose, conventional lipid profiles, blood pressure, and inflammation (e.g., C-reactive protein (CRP)), that are routinely used in clinical p

法官

Biomarker-Guided Therapy for Chronic Heart Failuregenesis of cardiac failure, has been steadily increasing. The circulating levels of brain natriuretic peptide (BNP) and N-terminal prohormone of BNP (NT-pro-BNP) are routinely used in clinical practice to stratify the risk of patients with symptomatic chronic heart failure. This chapter discusses th

macular-edema

總

PCSK9 as a Biomarker of Cardiovascular Diseaseve to measure its concentration in blood. Circulating PCSK9 exists in several forms – its parent form and a furin-cleaved form and a low-density lipoprotein (LDL)-bound form and a free form. The furin-cleaved and LDL-bound forms are much less active. Most studies have not clearly distinguished among

巨頭

initiate

無可非議

使堅硬